INFLIXIMAB-INDUCED LUPUS-LIKE SYNDROME IN A FEMALE PATIENT WITH RHEUMATOID ARTHRITIS (A CASE REPORT): AN ACCIDENT OR REGULARITY?
Open Access
- 29 September 2017
- journal article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 55 (4), 446-448
- https://doi.org/10.14412/1995-4484-2017-446-448
Abstract
The paper describes a case of infliximab-induced lupus-like syndrome in a female patient with rheumatoid arthritis and discusses the possible causes of this pathology.Keywords
This publication has 33 references indexed in Scilit:
- Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo ClinicMayo Clinic Proceedings, 2009
- Anti-TNF-induced lupusRheumatology, 2009
- Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α AgentsSeminars in Arthritis and Rheumatism, 2008
- Drug‐Induced LupusAnnals of the New York Academy of Sciences, 2007
- Drug-induced lupus: an updateLupus, 2006
- Problems encountered during anti-tumour necrosis factor therapyBest Practice & Research Clinical Rheumatology, 2006
- Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.Lupus, 2002
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- SENSITIVITY TO SULFADIAZINE RESEMBLING ACUTE DISSEMINATED LUPUS ERYTHEMATOSUSArchives of Dermatology, 1945